1.14.15.8	A106T	kcat/Km for conversion of 11-deoxycortisol is 3.17fold higher than wild-type value, 1.43fold increase in progesterone conversion	693956	
1.14.15.8	A106T/Q189K/T399S/R409L	kcat/Km for conversion of 11-deoxycortisol is 4.3fold higher than wild-type value, 1.13fold increase in progesterone conversion	693956	
1.14.15.8	A106T/R409L	kcat/Km for conversion of 11-deoxycortisol is 3fold higher than wild-type value, 1.43fold increase in progesterone conversion	693956	
1.14.15.8	A243S	mutant engineered for steroid 9alpha- and 6beta-hydroxylation, 10fold increase in the selectivity towards 6alpha-hydroxylation of progesterone. Mutant produces 3.4% 15beta-hydroxy-progesterone plus 4.6% 11alpha-hydroxy-progesterone plus 2.4% 9alpha-hydroxy-progesterone plus 82.7% 6beta-hydroxy-progesterone	746507	
1.14.15.8	A395L	Vmax/Km for progesterone is 2fold lower than wild-type value	697323	
1.14.15.8	D153V/I214F	kcat/Km for conversion of 11-deoxycortisol is 2.64fold higher than wild-type value, progesterone conversion is 93% of wild-type value	693956	
1.14.15.8	D217V	kcat/Km for conversion of 11-deoxycortisol is 2.68fold higher than wild-type value, 1.18fold increase in progesterone conversion	693956	
1.14.15.8	E90V/D185G	Vmax/Km for progesterone is 1.3fold higher than wild-type value	697323	
1.14.15.8	F165I	1.25fold increase in progesterone conversion	693956	
1.14.15.8	F165L/A395E/G397V	mutant engineered for steroid 9alpha- and 6beta-hydroxylation, 10fold increase in the selectivity towards progesterone 9lpha-hydroxylation. Mutant produces 11.3% 15beta-hydroxy-progesterone plus 17.2% 11alpha-hydroxy-progesterone plus 59.7% 9alpha-hydroxy-progesterone plus 6.8% 6beta-hydroxy-progesterone	746507	
1.14.15.8	G397P	the mutant exhibits 2% of the wild-type activity, Vmax/Km for progesterone is 51.7fold lower than wild-type value	697323	
1.14.15.8	I86T	Vmax/Km for progesterone is 2fold higher than wild-type value	697323	
1.14.15.8	K27R/I71T/I215T	Vmax/Km for progesterone is 2.5fold higher than wild-type value	697323	
1.14.15.8	additional information	construction of a CYP106A2 knockout strain	-, 711747	
1.14.15.8	additional information	modelling of CYP106A2 and site-directed mutagenesis of the protein to check the accuracy of the computer-derived model of CYP106A2	696142	
1.14.15.8	additional information	recombinant reconstitution of the whole cell conversion of 11-keto-beta-boswellic acid in Bacillus megaterium strain MS941 by coexpression of heterologous redox chain of the P450, bovine adrenodoxin reductase, and bovine adrenodoxin, as well as a a NADPH-regenerating system	-, 724061	
1.14.15.8	Q398S	Vmax/Km for progesterone is 5fold lower than wild-type value	697323	
1.14.15.8	S394I	Vmax/Km for progesterone is 7.5fold lower than wild-type value	697323	
1.14.15.8	S72A/V73I	mutant does not show a better stability in the crystallization process than the wild-type protein	696142	
1.14.15.8	T248V	specificity for 15beta-hydroxylation is improved	699068	
1.14.15.8	T396R	mutant does not produce any hydroxylated product up to an adrenodoxin concentration of 0.1 mM	697323